Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Gonzalez, Adán https://orcid.org/0000-0002-5078-139X
Carmona-Bayonas, Alberto https://orcid.org/0000-0002-1930-9660
Hernandez San Gil, Raquel https://orcid.org/0000-0003-3426-7515
Cruz-Castellanos, Patricia https://orcid.org/0000-0002-9837-825X
Antoñanzas-Basa, Mónica https://orcid.org/0000-0002-7434-9059
Lorente-Estelles, David https://orcid.org/0000-0001-7550-0657
Corral, María Jose https://orcid.org/0000-0001-8278-1370
González-Moya, Manuel https://orcid.org/0000-0002-1428-2745
Castillo-Trujillo, Oscar Alfredo https://orcid.org/0000-0001-7479-8658
Esteban, Emilio https://orcid.org/0000-0002-2980-5254
Jiménez-Fonseca, Paula https://orcid.org/0000-0003-4592-3813
Calderon, Caterina https://orcid.org/0000-0002-6956-9321
-
Funding
Funding for this research was provided by:
FSEOM (FSEOM 2018)
AstraZeneca España (ES-2020-3172)
- License Information
-
More Information
Article History
Received: 16 April 2023
Accepted: 2 May 2023
First Online: 29 May 2023
Declarations
:
: The authors have no relevant financial or non-financial interest to disclose.
: This study was approved by the Research Ethics Committee of the Principality of Asturias (May 17, 2019) and by the AEMPS (May 8, 2019; number: D57DG38BFB). The studies have been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. This study is an observational, non-interventionist trial.
: Signed informed consent was obtained from all patients.
: Informed consent and approval by the national competent authorities includes permission for publication and diffusion of the data was obtained.
